Researcher Patrick Grant, Ph.D., at Florida Atlantic University is utilizing epigenetics to develop better treatments for childhood acute lymphoblastic leukemia (ALL), a rare and aggressive blood cancer. While 90% of ALL patients survive beyond five

Researcher Diana J. Azzam and her team conducted a study on the feasibility of functional precision medicine (FPM) in treating relapsed or refractory pediatric cancers. By combining genomic profiling with drug sensitivity testing, FPM identified

Researcher Qing-Xiang Amy Sang at Florida State University is pioneering a study to develop a reliable model for atypical teratoid/rhabdoid tumor (ATRT), a rare and aggressive childhood brain cancer. Since over 95% of ATRT cases

Researcher Matthew D. Hall, MD, at Miami Cancer Institute led a study examining the long-term effects of radiation therapy on brain development in children with central nervous system tumors. Even small doses of radiation can

Damon Reed and his team at Moffitt Cancer Center are leading a phase II clinical trial investigating evolutionary inspired therapy for treating fusion-positive metastatic rhabdomyosarcoma. This study evaluates four different therapeutic treatments using chemotherapy drugs

Researcher Tamarah J. Westmoreland at Nemours Children’s Health is leading a groundbreaking study exploring the oncolytic potential of the Zika virus (ZIKV) in treating high-risk neuroblastoma. Neuroblastoma, a leading cause of childhood cancer-related deaths, often

Researcher Annette R. Khaled at the University of Central Florida College of Medicine led a study identifying Chaperonin-containing TCP-1 (CCT/TRiC) as a promising therapeutic and diagnostic target for neuroblastoma. This protein complex plays a key

Researcher Jonathan Licht at University of Florida Health, led a study and identified how a specific mutation in the NSD2 gene (E1099K) contributes to relapse in childhood acute lymphocytic leukemia (ALL). This mutation alters histone

Researcher Regina M. Graham at the University of Miami Miller School of Medicine led a study exploring the potential of carbon dots (CDs) in treating pediatric brain tumors. These highly adaptable nanoparticles can be modified

Researcher Mildred Acevedo-Duncan, Ph.D., at the University of South Florida is leading a study on the potential of PKC-i inhibitors in preventing the growth of neuroblastoma cells. With support from Live Like Bella, researchers at